- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
To elicit participant feedback regarding the COVID-19 session during the Fall 2020 Program Meeting.
Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), spoke Thursday, Jan. 7, about the state of the COVID-19 pandemic as part of Washington University Department of Medicine’s virtual, weekly Grand Rounds. The online talk — part of the Gerald Medoff Visiting Professor Grand Rounds lecture series — was free and open to
Tragically, the burdens of the COVID-19 pandemic often fall on the most vulnerable members of society. In this symposium, we will engage the broader Johns Hopkins community in a meaningful conversation on various aspects of disparities arising from the COVID-19 pandemic. Join us for an interactive discussion on how data science approaches and methods contribute to better understand, address, and
To elicit participant feedback on the 2020 Clinical Research in the COVID-era and Beyond Un-Meeting.
N3C is hosting an Open House to engage CTSA members, newcomers, and the wider translational research community. The event will be kicked off with a one-hour symposium that includes opening remarks from N3C leadership, followed by a PI/Clinician Testimonial with Dr. David Ellison of OCTRI, an N3C Tutorial on how to get involved, a demonstration of the N3C Data Enclave, and flash talks from the
The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is proud to share that two of our advisors have been named to the Community Advisory Board (CAB) for the National Institutes of Health Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. Robert Pearson, a member of our Participant Advisory Board (PAB), and Larisa Caicedo, a
NYU Center for the Study of Asian American Health (CSAAH) would like to share an NBC News article highlighting COVID-19 disparities among Asian subgroups: South Asian, Chinese New Yorkers among the hardest hit by Covid, study shows This article specifically highlights an important analysis of New York City Health and Hospitals (H+H) data on Asian Americans disparities in COVID, and was led by
The Irving Institute's Columbia Community Partnership for Health (CCPH), in partnership with the NYP Emergency Food Program, has been delivering groceries in upper Manhattan to 890 families each month during the COVID-19 pandemic. Watch the amazing community effort and impact that has resulted: https://vimeo.com/471555431
Melissa Haendel, PhD, FAMIA, Dan Housman, BSc, Hemalkumar Mehta, PhD, Charisse Madlock-Brown, PhD, MLS & Anita Walden, MA Researchers planning COVID-19 trials with the Trial Innovation Network (TIN) can leverage the N3C to inform their research hypotheses. N3C focuses on aligning its infrastructure so that it can generate efficient and minimally biased results. Part of that infrastructure includes
Researchers planning COVID-19 trials with the Trial Innovation Network (TIN) can leverage the N3C to inform their research hypotheses. N3C focuses on aligning its infrastructure so that it can generate efficient and minimally biased results. Part of that infrastructure includes the curation of value sets and phenotype variables relevant to COVID-19, such as ventilator support, ICU use, and
Learn more about obtaining patient-center feedback from underrepresented groups to enhance your research project even in the times of COVID. The CES Team will highlight it’s transition to the use of Zoom technology, how to address issues of tech-equity and literacy, and share lessons learned for effectively facilitating group dialogue in a virtual forum.
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.
Researchers at Washington University School of Medicine in St. Louis have received a two-year, $5 million grant to offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers and staff in the six special education schools operated by the Special School District of St. Louis County (SSD).
In 2015 Kenneth Remy, MD, MHSc arrived in St. Louis to join the Washington University School of Medicine faculty as an assistant professor of pediatrics and launched his lab studying the intersection of transfusion hematology and immune dysregulation. He was fresh off a National Institutes of Health (NIH) fellowship in Bethesda, Maryland, gaining experience that helped to shape his future career
We hear much these days about the FDA’s decision to provide an Emergency Use Authorization for a COVID-19 vaccine. Emergency Use Authorization, or EUA, is a process by which the FDA authorizes an unapproved product to be used for serious or life-threatening conditions when there are no adequate, approved and available alternatives. This can only occur during a public health emergency. On 11 Dec
The OSU CCTS and Nationwide Children's Hospital will be hosting our 2020 Annual Scientific Meeting on Jan. 12, 19, and 26, 2021, with a focus on using COVID-19 as a case study for best practices in clinical and translational science. This event will be held virtually. You can view the full agenda here.
Black churches have long been strongholds for sharing trusted health information with their communities, and never has that role been more important than during the COVID-19 pandemic. A new paper details how Mayo researchers are working with Black churches in MN to address COVID-19 health disparities.
The University of Wisconsin-Madison Department of Medicine is recruiting healthcare workers for the SHIELD Study to evaluate the use of nasal and oral antisepsis to prevent COVID-19. All participation can be done remotely, so healthcare workers in a wide range of roles across the US may be eligible to participate. Compensation may be available for participants. If you have any questions or are
Working towards a cure for HIV requires many things, including tenacity, determination, and collaboration. Nilu Goonetilleke, PhD – an immunologist in the University of North Carolina School of Medicine – is well-equipped to meet this challenge. Learn more about how Goonetilleke is changing the trajectory of HIV with research support from the North Carolina Translational and Clinical Sciences (NC
Janette Goins, RN, BSN has been awarded the 2020 Dean's Performance Award for Research. Goins serves as Director of Nursing for the North Carolina Translational and Clincial Sciences (NC TraCS) Institute's Clinical and Translational Research Center (CTRC) where she has made notable contributions to research processes and innovations supporting 208 research studies from 85 faculty. NC TraCS is the
Dr. Seble Kassaye, infectious disease expert at Georgetown University Medical Center and former GHUCCTS KL2 scholar, is the principal investigator for a local convalescent plasma COVID-19 clinical trial. Dr. Kassaye recently appeared on NBC4 Washington to discuss the trial. This trial is led by Johns Hopkins University. MedStar Georgetown University Hospital, MedStar Washington Hospital Center